X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

    Cell And Gene Therapy Boost With Novel UK Biotech Centres

    Monash University In Australia Leads $15M Mitochondrial Clinical Trial Drive

    Rapid Cutback of Intracranial Pressure By Injectable Peptide

    Tumors Can Get Destroyed By Bacteria-Aid To Immune System

    Tumors Can Get Destroyed By Bacteria-Aid To Immune System

    Default Eligibility Results In Better Clinical Trial Nods

    Researchers Develop Revolutionary Treatment In Bone Cancer

    Singapore Precision Drugs To Excel By Next-Gen Proteomics

    Temperature Stable TB Vaccine Gives Out Immune Response

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

    Cell And Gene Therapy Boost With Novel UK Biotech Centres

    Monash University In Australia Leads $15M Mitochondrial Clinical Trial Drive

    Rapid Cutback of Intracranial Pressure By Injectable Peptide

    Tumors Can Get Destroyed By Bacteria-Aid To Immune System

    Tumors Can Get Destroyed By Bacteria-Aid To Immune System

    Default Eligibility Results In Better Clinical Trial Nods

    Researchers Develop Revolutionary Treatment In Bone Cancer

    Singapore Precision Drugs To Excel By Next-Gen Proteomics

    Temperature Stable TB Vaccine Gives Out Immune Response

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Featured

Lonza To Construct $518mn Fill-Finish Plant In Switzerland

Content Team by Content Team
8th July 2022
in Featured, Manufacturing, Middle East and South Asia, News
Lonza To Construct $518mn Fill-Finish Plant In Switzerland

Lonza, a major CDMO, is to invest $518 million in a new, massive fill-finish manufacturing facility in Stein, Switzerland. According to the firm, the facility will use sustainable construction methods to lower carbon emissions when it is finished in 2026.

According to Lonza, the project would symbolise the achievement of the company’s ambition to provide comprehensive end-to-end CDMO services. The building will be situated on the same campus as the business’s current Stein facility for clinical medicinal products.

Lonza’s CEO, Pierre-Alain Ruffieux, said in a statement that “this strategic investment reinforces their position as a leading CDMO with an unrivalled variety of services across scales and technologies.”

Lonza has been expanding recently, similar to many CDMOs. The company’s laboratory expansion plan at its API production facility in Nansha, China, was finished in March. Lonza’s Guangzhou, China, factory, which had just opened for business earlier in the year, added a fill-finish line in August. The business also operates a factory in Suzhou, China, where it sells medication capsules and antimicrobial treatments. Lonza said in May of last year that it would spend $935 million to construct mammalian facilities at locations in Visp, Switzerland, and Portsmouth, New Hampshire.

Previous Post

Pfizer And Touchlight Enter Into A Patent Collaboration

Next Post

DoKaSch Temperature Solutions and Japan Airlines sign Master Rental Agreement

Related Posts

Clinical Trials

Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

18th March 2023
Featured

SVB Collapse And Its Implications On Biotechnology Sector

18th March 2023
Drug Development

Cell And Gene Therapy Boost With Novel UK Biotech Centres

18th March 2023
Featured

US President Looks To Double The Drugs For Price Negotiation

18th March 2023
Clinical Trials

Monash University In Australia Leads $15M Mitochondrial Clinical Trial Drive

18th March 2023
Drug Development

Rapid Cutback of Intracranial Pressure By Injectable Peptide

16th March 2023
Next Post
DoKaSch Temperature Solutions and Japan Airlines sign Master Rental Agreement

DoKaSch Temperature Solutions and Japan Airlines sign Master Rental Agreement

Latest News

Clinical Trials

Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

18th March 2023
Featured

SVB Collapse And Its Implications On Biotechnology Sector

18th March 2023
Drug Development

Cell And Gene Therapy Boost With Novel UK Biotech Centres

18th March 2023
Featured

US President Looks To Double The Drugs For Price Negotiation

18th March 2023
Clinical Trials

Monash University In Australia Leads $15M Mitochondrial Clinical Trial Drive

18th March 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In